BioCardia announces data verification completion for Phase 3 CardiAMP HF study on heart failure treatment, with results due March 30, 2025. BioCardia, Inc. has completed source data verification and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback